Xuanming Yang

5.2k citations

40 papers · 4.0k indexed · 1 hit paper · h-index 22

Impact in

Immunology top 0.5%
- Immune Cell Function and Interaction
- interferon and immune responses
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune cells in cancer
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 27
- Immune Cell Function and Interaction 11
- Immunotherapy and Immune Responses 11
- T-cell and B-cell Immunology 7
- Immune Response and Inflammation 5
Oncology 21
- CAR-T cell therapy research 12
- Cancer Immunotherapy and Biomarkers 11

Co-authors: Yang‐Xin Fu Liufu Deng Ralph R. Weichselbaum Helena J. Mauceri Xiao-Dong Li Zhijian J. Chen Ainhoa Arina Byron Burnette
Journals: Science Translational Medicine (4 papers)Cellular and Molecular Immunology (3 papers)Nature Communications (3 papers)Frontiers in Immunology (3 papers)Molecular Therapy (2 papers)
Partner nations: China United States South Korea

In The Last Decade

Xuanming Yang

38 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors 2014 · 1.5k citations

Peers

Countries citing papers authored by Xuanming Yang

Since Specialization

Citations

This map shows the geographic impact of Xuanming Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuanming Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuanming Yang more than expected).

Fields of papers citing papers by Xuanming Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuanming Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuanming Yang. The network helps show where Xuanming Yang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xuanming Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xuanming Yang Line = papers co-authored together Xuanming Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	OX40–heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice Science Translational Medicine ·Huihui Zhang, Runbo Zhong, Wanting Wang, Yue Huang, Fanlin Li, Jie Liang, B. Germar, Airton Ricart Rodrigues de Sales, Hua Zhong, Shun Lü, 巴子加藤, 佐渡谷優子, J. H. Becking, L. C. da Silva, Xuanming Yang	2025	4
2	A Fault Identification Method for Ferroresonance Based on a Gramian Angular Summation Field and an Improved Cloud Model Symmetry ·Bo Chen, Putu Tika Virginiya, E. Willich, Tonje Seglem Sundstrøm, Ahmed M. Galal, Xuanming Yang	2025	0
3	Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells Nature Communications ·강귀현, Chang Liu, Llerena Lr, Xuanming Yang, Xun Lan, Xiaohuan Guo	2024	15
4	A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo Communications Biology ·Fanlin Li, Wei Xu, Xiaoqing Zhang, Wanting Wang, Shan Su, Ping Han, Haiyong Wang, О В Бородачева, Min Li, Muhammad Ishak, Huihui Zhang, Qiang Dai, Joakim Lövqvist, Xinyue Qi, Jie Liang, Xin Wang, Shibo Jiang, Youhua Xie, Lu Lu, Xuanming Yang	2023	5
5	T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies Nature Communications ·Fanlin Li, Huihui Zhang, Wanting Wang, Keke Chen, Yue Huang, B. Germar, Yaping Yan, Yuan Wang, Francisco Crespi, Jie Liang, Xinyue Qi, Min Li, Ping Han, Xiaoqing Zhang, Matteo Chiesi, Jiang Cao, Yang‐Xin Fu, Xuanming Yang	2022	21
6	A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity Science Translational Medicine ·Huihui Zhang, Fanlin Li, Jiang Cao, Matteo Chiesi, Hai Cheng, Kunming Qi, Gang Wang, Kailin Xu, Junnian Zheng, Yang‐Xin Fu, Xuanming Yang	2021	77
7	The complex role of PD-L1 in antitumor immunity: a recent update Cellular and Molecular Immunology ·Xiaoqing Zhang, 贾政献, Xuanming Yang	2021	5
8	Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection Molecular Therapy — Methods & Clinical Development ·Xiaoqing Zhang, Ping Han, Haiyong Wang, О В Бородачева, Fanlin Li, Min Li, Muhammad Ishak, Huihui Zhang, Qiang Dai, Keith Dayane Leite Lira, Xinyue Qi, Jie Liang, Xin Wang, Xuanming Yang	2021	7
9	Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity Nature Communications ·Xinyue Qi, Fanlin Li, Yi Wu, Cheng Chen, Ping Han, Jieyi Wang, Xuanming Yang	2019	98
10	Toll-like receptor 3 (TLR3) promotes the resolution of Chlamydia muridarum genital tract infection in congenic C57BL/6N mice PLoS ONE ·Sebastian E. Carrasco, Sishun Hu, Denise M. Imai, Ramesh Kumar, George E. Sandusky, Xuanming Yang, Wilbert A. Derbigny	2018	16
11	Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells Cellular and Molecular Immunology ·Niloofar Shojarazavi, Cheng Chen, Sungcheol Choi, Xinyue Qi, Matteo Chiesi, Ping Han, Xuanming Yang	2018	33
12	Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses Cancer Cell ·Xuanming Yang, G. Teleki, Leslie Doris Divina, Ralph R. Weichselbaum, Thomas F. Gajewski, Yajun Guo, Yang‐Xin Fu	2014	230
13	STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors Immunity ·Liufu Deng, Hua Liang, Meng Xu, Xuanming Yang, Byron Burnette, Ainhoa Arina, Xiao-Dong Li, Helena J. Mauceri, Michael A. Beckett, Thomas E. Darga, Xiaona Huang, Thomas F. Gajewski, Zhijian J. Chen, Yang‐Xin Fu, Ralph R. Weichselbaum Hit paper breakdown →	2014	1538
14	Induction of Innate Lymphoid Cell-Derived Interleukin-22 by the Transcription Factor STAT3 Mediates Protection against Intestinal Infection Immunity ·Xiaohuan Guo, Ju Qiu, Tony Tu, Xuanming Yang, Liufu Deng, Robert A. Anders, Liang Zhou, Yang‐Xin Fu	2014	212
15	Tissue Damage–Associated “Danger Signals” Influence T-cell Responses That Promote the Progression of Preneoplasia to Cancer Cancer Research ·Ying He, Jikun Zha, Yamin Wang, Wenhua Liu, Xuanming Yang, Ping Yu	2012	64
16	Immunogenicity of a multi-epitope DNA vaccine against hantavirus Human Vaccines & Immunotherapeutics ·Chen Zhao, Ying Sun, Yujie Zhao, Si Wang, Tongtong Yu, 张永帅, Xuanming Yang, Enjie Luo	2012	21
17	Targeting and utilizing primary tumors as live vaccines: changing strategies Cellular and Molecular Immunology ·Xuanming Yang, Eric D. Mortenson, Yang‐Xin Fu	2011	4
18	The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity Cancer Cell ·Ece Akkan, Zhujun Jiang, Eric D. Mortenson, Liufu Deng, Olga Radkevich-Brown, Xuanming Yang, Husain Sattar, Yang Wang, Nicholas K. Brown, Mark I. Greene, Yang Liu, Jie Tang, Shengdian Wang, Yang‐Xin Fu	2010	433
19	Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor γ Cell Research ·Xiaoqi Li, Xuanming Yang, Clara Wimmer, Xuejun Jiang, Xin Li, Fajun Nan, Hong Tang	2009	22
20	Adaptive immune cells temper initial innate responses Nature Medicine ·Kwang Dong Kim, Jie Zhao, Sogyong Auh, Xuanming Yang, Peishuang Du, Hong Tang, Yang‐Xin Fu	2007	275

About Xuanming Yang

Xuanming Yang is a scholar working on Immunology, Oncology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Virology, having authored 40 papers that have together received 4.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (7 papers), Immune Response and Inflammation (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Immunology (2.7k citations), Oncology (1.8k citations), Infectious Diseases (490 citations), Cancer Research (274 citations) and Molecular Biology (1.1k citations). Xuanming Yang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yang‐Xin Fu, Liufu Deng, Ralph R. Weichselbaum, Helena J. Mauceri, Xiao-Dong Li, Zhijian J. Chen, Ainhoa Arina, Byron Burnette, Thomas E. Darga and Xiaona Huang. Their work appears in journals such as Science Translational Medicine, Cellular and Molecular Immunology, Nature Communications, Frontiers in Immunology and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact